Dr Joachim Ermer
Ermer Quality Consulting

Ermer Quality Consulting
The regulatory requirements to validation of analytical procedures utilised for release and stability studies of drug substances and drug products are described in the ICH guideline Q2(R2). However, its degree of detail is rather low, and the examples provided in Annex 2 often lack orientation beyond the guideline text. Therefore, this Live Online Training provides besides these regulatory expectations practical interpretation and recommendations for demonstration of the suitability of analytical procedures. The revision of the USP General Information Chapter <1225> “Validation of Analytical Procedures”, published November 2025 provides urgently needed interpretation of some neglected aspects in the ICH guideline Q2(R2), for example with respect to precision levels, replication strategy for the reportable result, and acceptance criteria.
The ICH Q2(R2)/Q14 Training Materials published in July 2025 is critically discussed, emphasizing some deficiencies and gaps, for example the inappropriate mixing of precision levels, or the lack of orientation how to derive appropriate acceptance criteria or to establish a suitable replication strategy.
A rational and efficient validation approach is ultimately based on the respective routine application, which should be reflected in the validation design. This includes the identification of the relevant performance parameters, the selection of appropriate tests and calculations and, in particular, the establishment of acceptance criteria for the Evaluation.
These recommendations are illustrated by practical exercises, demonstrations, and interactive polls/discussions (Mentimeter based).
| ECA-Member*: | € 1090,- |
| Regular Fee*: | € 1290,- |
| EU/GMP Inspectorates*: | € 645,- |
| APIC Member Discount*: | € 1190,- |
Alle Preise zzgl. MwSt. Wichtige Hinweise zur Umsatzsteuer.
Wir stehen Ihnen für weitere Auskünfte gerne zur Verfügung.
Teilnehmerstimmen - das sagen andere über unsere Seminare: